Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Subhashis Banerjee

Showing results (31-40 of 111) with videos related to

Pageof 12
Sort By:
ACR Open Rheumatology|November 29, 2019
Safety of Abatacept Versus Placebo in Rheumatoid Arthritis: Integrated Data Analysis of Nine Clinical TrialsTeresa A Simon, Benjamin P Soule, Marc Hochberg, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 10, 2016
The Efficacy and Safety of Clazakizumab, an Anti-Interleukin-6 Monoclonal Antibody, in a Phase IIb Study of Adults With Active Psoriatic ArthritisPhilip J Mease, Alice B Gottlieb, Alberto Berman, et al.
Antimicrobial Agents and Chemotherapy|November 30, 2011
Pharmacokinetic effects of coadministration of lersivirine with raltegravir or maraviroc in healthy subjectsManoli Vourvahis, Grant Langdon, Robert R Labadie, et al.
Rheumatology International|May 2, 2020
Poor prognostic factors in predicting abatacept response in a phase III randomized controlled trial in psoriatic arthritisPhilip J Mease, Iain B McInnes, Vibeke Strand, et al.
Journal of Clinical Pharmacology|April 23, 2014
Population exposure-response model to support dosing evaluation of ixekizumab in patients with chronic plaque psoriasisLai-San Tham, Cheng-Cai Tang, Siak-Leng Choi, et al.
The New England Journal of Medicine|March 30, 2012
Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasisCraig Leonardi, Robert Matheson, Claus Zachariae, et al.
Scientific Reports|July 8, 2022
Ultra-high resolution, multi-scale, context-aware approach for detection of small cancers on mammographyKrithika Rangarajan, Aman Gupta, Saptarshi Dasgupta, et al.
World Neurosurgery|February 5, 2020
A Review of Physical Simulators for Neuroendoscopy Skills TrainingBritty Baby, Ramandeep Singh, Rajdeep Singh, et al.
Neurosurgical Review|August 25, 2019
A review of virtual reality simulators for neuroendoscopyBritty Baby, Ramandeep Singh, Ashish Suri, et al.
The Journal of Dermatology|January 25, 2024
Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in Japanese patients with moderate to severe plaque, erythrodermic, or generalized pustular psoriasis: Efficacy and safety results from an open-label, phase 3 trialShinichi Imafuku, Yukari Okubo, Yayoi Tada, et al.
Pageof 12

Showing results (31-40 of 111) with videos related to

Sort By:
Pageof 12
ACR Open Rheumatology|November 29, 2019
Safety of Abatacept Versus Placebo in Rheumatoid Arthritis: Integrated Data Analysis of Nine Clinical TrialsTeresa A Simon, Benjamin P Soule, Marc Hochberg, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 10, 2016
The Efficacy and Safety of Clazakizumab, an Anti-Interleukin-6 Monoclonal Antibody, in a Phase IIb Study of Adults With Active Psoriatic ArthritisPhilip J Mease, Alice B Gottlieb, Alberto Berman, et al.
Antimicrobial Agents and Chemotherapy|November 30, 2011
Pharmacokinetic effects of coadministration of lersivirine with raltegravir or maraviroc in healthy subjectsManoli Vourvahis, Grant Langdon, Robert R Labadie, et al.
Rheumatology International|May 2, 2020
Poor prognostic factors in predicting abatacept response in a phase III randomized controlled trial in psoriatic arthritisPhilip J Mease, Iain B McInnes, Vibeke Strand, et al.
Journal of Clinical Pharmacology|April 23, 2014
Population exposure-response model to support dosing evaluation of ixekizumab in patients with chronic plaque psoriasisLai-San Tham, Cheng-Cai Tang, Siak-Leng Choi, et al.
The New England Journal of Medicine|March 30, 2012
Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasisCraig Leonardi, Robert Matheson, Claus Zachariae, et al.
Scientific Reports|July 8, 2022
Ultra-high resolution, multi-scale, context-aware approach for detection of small cancers on mammographyKrithika Rangarajan, Aman Gupta, Saptarshi Dasgupta, et al.
World Neurosurgery|February 5, 2020
A Review of Physical Simulators for Neuroendoscopy Skills TrainingBritty Baby, Ramandeep Singh, Rajdeep Singh, et al.
Neurosurgical Review|August 25, 2019
A review of virtual reality simulators for neuroendoscopyBritty Baby, Ramandeep Singh, Ashish Suri, et al.
The Journal of Dermatology|January 25, 2024
Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in Japanese patients with moderate to severe plaque, erythrodermic, or generalized pustular psoriasis: Efficacy and safety results from an open-label, phase 3 trialShinichi Imafuku, Yukari Okubo, Yayoi Tada, et al.
Pageof 12